Literature DB >> 11886019

Psychopharmacology and aggression. I: A meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD.

Daniel F Connor1, Stephen J Glatt, Ivan D Lopez, Denise Jackson, Richard H Melloni.   

Abstract

OBJECTIVE: To determine by meta-analysis the effect size for stimulants on overt and covert aggression-related behaviors in children with attention-deficit/hyperactivity disorder (ADHD), separately from stimulant effects on the core symptoms of ADHD.
METHOD: A review of the literature from 1970 to 2001 revealed 28 studies meeting inclusion/exclusion criteria for meta-analysis. These studies yielded 28 independent effects of overt aggression and 7 independent effects of covert aggression.
RESULTS: The overall weighted mean effect size was 0.84 for overt and 0.69 for covert aggression related behaviors in ADHD. Comorbid conduct disorder is associated with diminishing stimulant effect size for overt aggression.
CONCLUSION: Stimulant effects for aggression-related behaviors in ADHD have effect sizes similar to those for the core symptoms of ADHD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11886019     DOI: 10.1097/00004583-200203000-00004

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  62 in total

1.  The dopamine dilemma: using stimulants and antipsychotics concurrently.

Authors:  Jason Yanofski
Journal:  Psychiatry (Edgmont)       Date:  2010-06

2.  Risperidone added to parent training and stimulant medication: effects on attention-deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression.

Authors:  Kenneth D Gadow; L Eugene Arnold; Brooke S G Molina; Robert L Findling; Oscar G Bukstein; Nicole V Brown; Nora K McNamara; E Victoria Rundberg-Rivera; Xiaobai Li; Heidi L Kipp; Jayne Schneider; Cristan A Farmer; Jennifer L Baker; Joyce Sprafkin; Robert R Rice; Srihari S Bangalore; Eric M Butter; Kristin A Buchan-Page; Elizabeth A Hurt; Adrienne B Austin; Sabrina N Grondhuis; Michael G Aman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-06-12       Impact factor: 8.829

3.  Conduct disorders and us: from heart sink to heart warming?

Authors:  Daphne V Keen
Journal:  Arch Dis Child       Date:  2007-10       Impact factor: 3.791

Review 4.  The developmental psychopathology of irritability.

Authors:  Ellen Leibenluft; Joel Stoddard
Journal:  Dev Psychopathol       Date:  2013-11

5.  Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation.

Authors:  Daniel P Dickstein; Kenneth E Towbin; Jan Willem Van Der Veen; Brendan A Rich; Melissa A Brotman; Lisa Knopf; Laura Onelio; Daniel S Pine; Ellen Leibenluft
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-02       Impact factor: 2.576

6.  Effects of behavioral and pharmacological therapies on peer reinforcement of deviancy in children with ADHD-only, ADHD and conduct problems, and controls.

Authors:  Sarah A Helseth; Daniel A Waschbusch; Elizabeth M Gnagy; Adia N Onyango; Lisa Burrows-MacLean; Gregory A Fabiano; Erika K Coles; Anil Chacko; Brian T Wymbs; Kathryn S Walker; Frances A Wymbs; Allison Garefino; Greta M Massetti; Jessica Robb Mazzant; Martin T Hoffman; James G Waxmonsky; Kristin Nichols-Lopez; William E Pelham
Journal:  J Consult Clin Psychol       Date:  2014-12-15

Review 7.  Prescription stimulant medication misuse: Where are we and where do we go from here?

Authors:  Lisa L Weyandt; Danielle R Oster; Marisa E Marraccini; Bergljot Gyda Gudmundsdottir; Bailey A Munro; Emma S Rathkey; Alison McCallum
Journal:  Exp Clin Psychopharmacol       Date:  2016-10       Impact factor: 3.157

Review 8.  Evidence-based treatments for youths with severely dysregulated mood: a qualitative systematic review of trials for SMD and DMDD.

Authors:  Xavier Benarous; Angèle Consoli; Jean-Marc Guilé; Sébastien Garny de La Rivière; David Cohen; Bertrand Olliac
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-09-23       Impact factor: 4.785

Review 9.  Conduct disorders.

Authors:  Jan K Buitelaar; Kirsten C Smeets; Pierre Herpers; Floor Scheepers; Jeffrey Glennon; Nanda N J Rommelse
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-02       Impact factor: 4.785

Review 10.  Antipsychotic and psychostimulant drug combination therapy in attention deficit/hyperactivity and disruptive behavior disorders: a systematic review of efficacy and tolerability.

Authors:  David Linton; Alasdair M Barr; William G Honer; Ric M Procyshyn
Journal:  Curr Psychiatry Rep       Date:  2013-05       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.